Quipt Home Medical Future Growth

Future criteria checks 4/6

Quipt Home Medical is forecast to grow earnings and revenue by 54.8% and 16.2% per annum respectively while EPS is expected to grow by 52% per annum.

Key information

54.8%

Earnings growth rate

52.0%

EPS growth rate

Healthcare earnings growth	109.4%
Revenue growth rate	16.2%
Future return on equity	n/a
Analyst coverage	Good
Last updated	03 Apr 2024

Recent future growth updates

Quipt Home Medical Corp. (TSE:QIPT) Just Released Its First-Quarter Results And Analysts Are Updating Their Estimates

Feb 17

Recent updates

Investors Aren't Entirely Convinced By Quipt Home Medical Corp.'s (TSE:QIPT) Revenues

Apr 19

Quipt Home Medical Corp. (TSE:QIPT) Just Released Its First-Quarter Results And Analysts Are Updating Their Estimates

Feb 17

Earnings Update: Quipt Home Medical Corp. (CVE:QIPT) Just Reported Its Third-Quarter Results And Analysts Are Updating Their Forecasts

Aug 18

Health Check: How Prudently Does Quipt Home Medical (CVE:QIPT) Use Debt?

Jul 13

When Should You Buy Quipt Home Medical Corp. (CVE:QIPT)?

Jun 08

Quipt Home Medical Corp. (CVE:QIPT) Shares Could Be 43% Below Their Intrinsic Value Estimate

Jun 02

Does Protech Home Medical (CVE:PTQ) Have A Healthy Balance Sheet?

May 07

Protech Home Medical Corp. (CVE:PTQ) Could Be Less Than A Year Away From Profitability

Mar 29

Can You Imagine How Elated Protech Home Medical's (CVE:PTQ) Shareholders Feel About Its 331% Share Price Gain?

Feb 22

Calculating The Fair Value Of Protech Home Medical Corp. (CVE:PTQ)

Jan 18

Earnings and Revenue Growth Forecasts

TSX:QIPT - Analysts future estimates and past financials data (USD Millions)
Date	Revenue	Earnings	Free Cash Flow	Cash from Op	Avg. No. Analysts
9/30/2026	351	18	N/A	N/A	2
9/30/2025	290	7	N/A	N/A	6
9/30/2024	267	0	45	52	8
12/31/2023	236	-4	40	47	N/A
9/30/2023	212	-3	34	41	N/A
6/30/2023	189	0	26	34	N/A
3/31/2023	164	2	19	29	N/A
12/31/2022	139	7	17	26	N/A
9/30/2022	128	5	17	26	N/A
6/30/2022	118	2	17	26	N/A
3/31/2022	109	8	15	23	N/A
12/31/2021	99	-10	14	20	N/A
9/30/2021	94	-6	13	18	N/A
6/30/2021	87	-5	13	16	N/A
3/31/2021	81	-14	14	15	N/A
12/31/2020	79	1	13	14	N/A
9/30/2020	73	-4	14	14	N/A
6/30/2020	67	0	19	19	N/A
3/31/2020	62	-6	10	10	N/A
12/31/2019	63	-11	10	10	N/A
9/30/2019	61	-7	8	8	N/A
6/30/2019	57	-27	10	2	N/A
3/31/2019	56	-18	14	11	N/A
12/31/2018	53	-20	10	10	N/A
9/30/2018	55	-7	10	11	N/A
6/30/2018	59	-6	-5	-4	N/A
3/31/2018	59	-7	-6	-3	N/A
12/31/2017	61	-4	-8	-6	N/A
9/30/2017	61	-22	N/A	-5	N/A
6/30/2017	36	-16	N/A	1	N/A
3/31/2017	45	-19	N/A	-8	N/A
12/31/2016	56	-29	N/A	-7	N/A
9/30/2016	73	-28	N/A	-12	N/A
6/30/2016	105	-18	N/A	-9	N/A
3/31/2016	94	-25	N/A	-10	N/A
12/31/2015	73	-16	N/A	-6	N/A
9/30/2015	54	-18	N/A	-2	N/A
6/30/2015	42	-21	N/A	-4	N/A
3/31/2015	30	-7	N/A	3	N/A
12/31/2014	25	-4	N/A	0	N/A
9/30/2014	19	-1	N/A	-1	N/A
6/30/2014	12	0	N/A	0	N/A
3/31/2014	7	-1	N/A	-1	N/A
12/31/2013	5	-2	N/A	-1	N/A
9/30/2013	4	-2	N/A	-1	N/A
6/30/2013	4	0	N/A	0	N/A

Analyst Future Growth Forecasts

Earnings vs Savings Rate: QIPT is forecast to become profitable over the next 3 years, which is considered faster growth than the savings rate (2.1%).

Earnings vs Market: QIPT is forecast to become profitable over the next 3 years, which is considered above average market growth.

High Growth Earnings: QIPT is expected to become profitable in the next 3 years.

Revenue vs Market: QIPT's revenue (16.2% per year) is forecast to grow faster than the Canadian market (6.6% per year).

High Growth Revenue: QIPT's revenue (16.2% per year) is forecast to grow slower than 20% per year.

Earnings per Share Growth Forecasts

Future Return on Equity

Future ROE: Insufficient data to determine if QIPT's Return on Equity is forecast to be high in 3 years time

Quipt Home Medical Future Growth

Future criteria checks 4/6

Key information

Recent future growth updates

Quipt Home Medical Corp. (TSE:QIPT) Just Released Its First-Quarter Results And Analysts Are Updating Their Estimates

Consensus EPS estimates fall by 97%

Consensus EPS estimates fall by 98%

Consensus EPS estimates fall by 80%, revenue upgraded

Consensus EPS estimates fall by 19%

Consensus EPS estimates fall by 20%

Recent updates

Investors Aren't Entirely Convinced By Quipt Home Medical Corp.'s (TSE:QIPT) Revenues

Quipt Home Medical Corp. (TSE:QIPT) Just Released Its First-Quarter Results And Analysts Are Updating Their Estimates

First quarter 2024 earnings: EPS and revenues exceed analyst expectations

Quipt Home Medical Corp., Annual General Meeting, Mar 27, 2024

Quipt Home Medical Corp. to Report Q1, 2024 Results on Feb 14, 2024

Full year 2023 earnings: EPS and revenues miss analyst expectations

Quipt Home Medical Corp. to Report Q4, 2023 Results on Dec 18, 2023

Now 21% undervalued after recent price drop

What Is Quipt Home Medical Corp.'s (TSE:QIPT) Share Price Doing?

Consensus EPS estimates fall by 97%

Calculating The Fair Value Of Quipt Home Medical Corp. (TSE:QIPT)

Consensus EPS estimates fall by 98%

Third quarter 2023 earnings: EPS misses analyst expectations

Quipt Home Medical Corp.(TSXV:QIPT) dropped from S&P/TSX Venture Composite Index

Now 21% undervalued after recent price drop

Consensus EPS estimates fall by 80%, revenue upgraded

Second quarter 2023 earnings: Revenues exceed analysts expectations while EPS lags behind

Consensus EPS estimates fall by 19%

Consensus EPS estimates fall by 20%

We Think Quipt Home Medical's (CVE:QIPT) Robust Earnings Are Conservative

Consensus EPS estimates increase by 37%

First quarter 2023 earnings: EPS exceeds analyst expectations while revenues lag behind

Quipt Home Medical Corp., Annual General Meeting, Mar 24, 2023

Consensus revenue estimates increase by 21%

Investor sentiment improved over the past week

Consensus EPS estimates fall by 47%

Full year 2022 earnings: EPS and revenues exceed analyst expectations

Earnings Update: Quipt Home Medical Corp. (CVE:QIPT) Just Reported Its Third-Quarter Results And Analysts Are Updating Their Forecasts

Consensus forecasts updated

Health Check: How Prudently Does Quipt Home Medical (CVE:QIPT) Use Debt?

Quipt Home Medical Corp. (TSXV : QIPT) acquired Hometown Medical, LLC.

Quipt Home Medical Corp. Reiterates Outlook for 2022

Quipt Home Medical Corp. (TSXV:QIPT) acquired Norcal Respiratory, Inc. for $3.1 million.

When Should You Buy Quipt Home Medical Corp. (CVE:QIPT)?

Second quarter 2022 earnings: EPS exceeds analyst expectations

Quipt Home Medical Corp. Reiterates Revenue Guidance for the First Quarter of Fiscal Year 2023

Quipt Home Medical Corp., Annual General Meeting, Jun 02, 2022

Quipt Home Medical Corp. Provides Earnings Guidance for the First Quarter of Fiscal Year 2023

Quipt Home Medical Corp. Appoints Brian J. Wessel as an Independent Director and Chair of the Audit Committee

Forecast breakeven date pushed back to 2023

Full year 2021 earnings: EPS misses analyst expectations

Quipt Home Medical Corp Receives Letter from Nasdaq Notifying Nom-Compliance

Quipt Home Medical Corp. Reiterates Earnings Guidance for the Fiscal Year 2022

Quipt Home Medical Corp. (TSXV:QIPT) completed the acquisition of At Home Health Equipment, Inc. for approximately $13.1 million.

Quipt Home Medical Corp. Provides Earnings Guidance for the Fiscal Year 2022

Third quarter 2021 earnings released: EPS US$0.20 (vs US$0.12 loss in 3Q 2020)

Quipt Home Medical Corp. (TSXV:QIPT) acquired Medical West Healthcare Center, LLC for $2.4 million.

Forecast breakeven moved forward to 2021

Quipt Home Medical Corp. (CVE:QIPT) Shares Could Be 43% Below Their Intrinsic Value Estimate

Does Protech Home Medical (CVE:PTQ) Have A Healthy Balance Sheet?

Protech Home Medical Corp. (CVE:PTQ) Could Be Less Than A Year Away From Profitability

First quarter 2021 earnings released: EPS US$0.002 (vs US$0.016 loss in 1Q 2020)

Can You Imagine How Elated Protech Home Medical's (CVE:PTQ) Shareholders Feel About Its 331% Share Price Gain?

Protech Home Medical Corp., Annual General Meeting, Apr 19, 2021

Protech Home Medical Corp. (TSXV:PTQ) completed the acquisition of Mayhugh's Medical Equipment for $5.8 million.

Price target raised to CA$2.95

Full year 2020 earnings released: CA$0.062 loss per share (vs CA$0.11 loss in FY 2019)

Earnings beat expectations, revenue disappoints

New 90-day high: CA$2.18

Protech Home Medical Corp. to Report Q4, 2020 Results on Jan 29, 2021

Calculating The Fair Value Of Protech Home Medical Corp. (CVE:PTQ)

New 90-day high: CA$1.73

Analysts update estimates

Protech Home Medical Announces That Kevin A. Carter Has Joined the Board of Directors as an Independent Director

Price target raised to CA$2.53

New 90-day high: CA$1.68

Analysts update estimates

Protech Home Medical Corp. (TSXV:PTQ) completed the acquisition of Sleepwell, LLC for $14.4 million.

New 90-day high: CA$1.46